97 Results for "

Fatty Acid Amide

" in MedChemExpress (MCE) Product Catalog:
Products (97)

97 Results for "Fatty Acid Amide" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-14595
CAS No.: 491-80-5
Purity:  99.29%
Synonyms: 4-Methylgenistein; Olmelin
Biochanin A is a naturally occurring fatty acid amide hydrolase (FAAH) inhibitor, which inhibits FAAH with IC50s of 1.8, 1.4 and 2.4 μM for mouse, rat, and human FAAH, respectively.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0182
CAS No.: 61422-45-5
Synonyms: HCFU
Carmofur (HCFU) is a rat recombinant acid ceramidase inhibitor with an IC50 of 29 nM. Carmofur is also a protease inhibitor of SARS-CoV-2 main protease (Mpro), fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA). Carmofur has anti-cancer, anti-inflammatory and anti-virus activities, and can be used for the study of COVID-19 and acute lung injury (ALI) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15250
CAS No.: 1210004-12-8
Purity:  99.75%
Target:  

FAAH MAGL Autophagy

Research Areas:  

Neurological Disease

JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10865
CAS No.: 874902-19-9
Purity:  98.01%
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14380
CAS No.: 1196109-52-0
Purity:  99.95%
Target:  

FAAH Autophagy

Research Areas:  

Inflammation/Immunology Cancer

PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 μM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2365
CAS No.: 74058-71-2
Synonyms: N-BenzylpalmitAmide; N-BenzylhexadecanAmide; MacAmide 1
Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19740
CAS No.: 1233855-46-3
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2327
CAS No.: 301-02-0
Oleamide is an endogenous fatty acid amide which can be synthesized de novo in the mammalian nervous system, and has been detected in human plasma.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119283
CAS No.: 359714-55-9
Purity:  99.58%
Synonyms: MAGL-IN-5
CAY10499 (MAGL-IN-5) is a non-selective lipase inhibitor with IC50 values of 144 nM and 14 nM for monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. Additionally, CAY10499 exhibits anti-inflammatory and antiviral activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3033
CAS No.: 883715-18-2
N-​Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM .
loading...
    loading...
Cat. No.: HY-121389
CAS No.: 629-54-9
Purity:  ≥97.0%
Synonyms: PalmitAmide
Hexadecanamide (Palmitamide) is a fatty acid amide that has orally active anti-allergic, antioxidant, and neuroprotective effects. Hexadecanamide exerts protective effects in Staphylococcus aureus- and SARA-induced mastitis. Hexadecanamide suppresses S. aureus-induced activation of the NF-κB pathway and improves blood-milk barrier integrity. Hexadecanamide activates PPARα. Hexadecanamide enhances sperm motility in vitro. Hexadecanamide can be studied in research for mastitis and asthenozoospermia .
loading...
    loading...
Cat. No.: HY-W130610
CAS No.: 124-26-5
Stearamide is a primary fatty acid amide. Stearamide displays cytotoxic and ichthytoxic activity .
loading...
    loading...
Cat. No.: HY-110138
CAS No.: 861891-72-7
Purity:  99.70%
Target:  

FAAH

Research Areas:  

Others

PDP-EA is a compound that increases the amidohydrolase activity of FAAH (fatty acid amide hydrolase) .
loading...
    loading...
Cat. No.: HY-117401
CAS No.: 107827-77-0
Purity:  99.32%
5-Dodecanoylaminofluorescein is an amphipathic (amphoteric) fluorescent probe (Ex/Em = 485 nm/515-535 nm), which consists of a hydrophilic fluorescein core and a hydrophobic dodecanoyl group (C12 fatty acid chain) linked by an amide bond. 5-Dodecanoylaminofluorescein is mainly used as an interface-localized radical trapping/indicator probe. Dodecanoylaminofluorescein can be used for the determination of the antioxidant properties of emulsions, or can serve as a lipophilic drug model for the study of passive skin penetration when encapsulated in tyrosine-derived nanospheres .
loading...
    loading...
Cat. No.: HY-N6723
CAS No.: 116355-84-1
Fumonisin B2 is a selective ceramide synthase inhibitor and carcinogenic mycotoxin with toxicity comparable to that of Fumonisin B1 (HY-N6719). Fumonisin B2 inhibits de novo sphingolipid biosynthesis by blocking the amide bond formation between fatty acids and dihydrosphingosine, which leads to a massive intracellular accumulation of free dihydrosphingosine, altered sphingosine levels, subsequent inhibition of cell proliferation, and induction of cell death. Fumonisin B2 is used to investigate the pathogenesis of diseases associated with Fusarium verticillioides contamination, including equine leukoencephalomalacia, porcine pulmonary edema syndrome, human esophageal cancer, and rat hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-18081
CAS No.: 959151-50-9
Target:  

FAAH

Research Areas:  

Metabolic Disease

PF 750 is a selective, covalent and brain-penetrant fatty acid amide hydrolase (FAAH) inhibitor. PF 750 covalently carbamylates FAAH's catalytic serine nucleophile to inactivate the enzyme .
loading...
    loading...
Cat. No.: HY-N7062
CAS No.: 681136-29-8
Synonyms: Takeda-25
Target:  

FAAH

Research Areas:  

Neurological Disease

JNJ-1661010 (Takeda-25) a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 34 and 33 nM for rat FAAH and human FAAH, respectively. JNJ-1661010 can cross the blood-brain barrier and used as broad-spectrum analgesics .
loading...
    loading...
Cat. No.: HY-120961
CAS No.: 85075-82-7
Synonyms: N-EthyloleAmide
Target:  

FAAH

Research Areas:  

Metabolic Disease

Oleoyl ethyl amide (N-Ethyloleamide) is a fatty acid amide hydrolase (FAAH) inhibitor. Oleoyl ethyl amide can counteract bladder overactivity .
loading...
    loading...
Cat. No.: HY-125967
CAS No.: 86855-26-7
Purity:  ≥97.0%
Target:  

FAAH

Research Areas:  

Neurological Disease

AM 374 is an fatty acid amide hydrolase (FAAH) inhibitor. AM 374 inhibits amidase activity with an IC50 value of 13 nM. AM 374 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-101457
CAS No.: 1672691-74-5
Purity:  99.74%
Target:  

MAGL

Research Areas:  

Metabolic Disease

JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL) .
loading...
    loading...